IL230335A
(en )
2015-07-30
Composition for treatment of cartilage disease
HK1131141A1
(en )
2010-01-15
Imidazolothiazole compounds for the treatment of disease
EP1996612A4
(en )
2010-10-20
Compositions for treatment of cancer
EP2119477A4
(en )
2012-02-29
Composition for treatment of xerostomy or dry mouth
IL232619A0
(en )
2014-06-30
Compositions suitable for treatment of spinal disease, disorder or condition
HK1164149A1
(en )
2012-09-21
Compositions for the treatment of gastro-esofageal reflux disease (gerd) -(gerd)
EP2148708A4
(en )
2012-12-05
Composition for enhancing bone formation
EP2160100A4
(en )
2011-08-31
Treatment of graft-versus-host disease
EP2411006A4
(en )
2012-08-22
Compositions and methods for treatment of renal disease
PL2358373T3
(en )
2016-02-29
Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases
EP2271352A4
(en )
2014-01-15
Compositions and methods for treatment of neoplastic disease
GB0707750D0
(en )
2007-05-30
Treatment of organic matter
HK1141708A1
(en )
2010-11-19
Agent for treatment of pulmonary disease
GB0909297D0
(en )
2009-07-15
Composition for the treatment of skin conditions
EP2210621A4
(en )
2010-11-17
Composition for treatment of joint disease
EP2213303A4
(en )
2011-12-28
Pharmaceutical composition for treatment of cataract
HK1154797A1
(en )
2012-05-04
Composition for treating disease
IL209819A0
(en )
2011-02-28
Novel heterocyclyl compounds for treatment of cardiovascular disease
EP2174956A4
(en )
2011-05-25
Compositions for anti-fibrinolitic treatment
HK1147064A1
(en )
2011-07-29
Pharmaceutical compositions for treating anxiety
IL208624A0
(en )
2010-12-30
Compositions for the treatment of lice
GB0723100D0
(en )
2008-01-02
Treatment of HFnEF
PL2252302T3
(en )
2014-05-30
Composition for the treatment of osteoarthritis
GB0623740D0
(en )
2007-01-10
Treatment of disease
HUP0500947A2
(en )
2007-08-28
Composition for treatment of paradontosis